FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W45403062> ?p ?o ?g. }

• W45403062 endingPage "23" @default.
• W45403062 startingPage "416" @default.
• W45403062 abstract "The administration of cortisone acetate to patients with rheumatoid arthritis usually produces prompt and often dramatic suppression of the disease manifestations. The effects of the hormone are not lasting, however, and after withdrawal relapse ensues. For sustained improvement in a chronic disease such as rheumatoid arthritis, it appears that cortisone must be given more or less continuously. This raises the question whether administration may be continued effectively and safely for long periods.Seventy-six patients with rheumatoid arthritis were given cortisone in the hope that treatment could be continued uninterruptedly for extended periods. For various clinical reasons it was necessary to discontinue treatment in 16 of these before six months, but the remaining 60 patients received the hormone uninterruptedly for six to 15 months. By using initial large suppressive amounts, then gradually reducing the dosage, and finally employing smaller maintenance doses, adequate degrees of rheumatic control were maintained in approximately two-thirds of the original 76 patients. The ability to sustain satisfactory improvement varied indirectly, in general, with the severity of the rheumatoid arthritis. The chief detriment to better results in the more severe cases was the intervention of adverse hormonal side effects which developed frequently when large or relatively large maintenance doses were required to support satisfactory improvement. Unwanted signs of hormonal excess developed in 40 per cent of cases at some time during the course of treatment. Most of them were mild or transient and disappeared or lessened when the dose of cortisone was reduced, but when the dose was reduced the degree of improvement often declined also. During prolonged cortisone therapy evidence of functional suppression of the adrenal cortices, as indicated by a decreased response of circulating eosinophils to exogenous ACTH, was present. The depression of cortical function was temporary, however. Whether irreversible damage may result when the drug is employed for longer periods cannot yet be answered." @default.
• W45403062 created "2016-06-24" @default.
• W45403062 creator A5039432100 @default.
• W45403062 creator A5091717071 @default.
• W45403062 date "1951-06-01" @default.
• W45403062 modified "2023-09-23" @default.
• W45403062 title "Results of long-continued cortisone administration in rheumatoid arthritis." @default.
• W45403062 cites W1967710508 @default.
• W45403062 cites W1986388594 @default.
• W45403062 cites W1994443194 @default.
• W45403062 cites W2018690710 @default.
• W45403062 cites W2034626256 @default.
• W45403062 cites W2062209205 @default.
• W45403062 cites W2075839177 @default.
• W45403062 cites W2097532396 @default.
• W45403062 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1520676" @default.
• W45403062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14848703" @default.
• W45403062 hasPublicationYear "1951" @default.
• W45403062 type Work @default.
• W45403062 sameAs 45403062 @default.
• W45403062 citedByCount "11" @default.
• W45403062 countsByYear W454030622012 @default.
• W45403062 countsByYear W454030622014 @default.
• W45403062 crossrefType "journal-article" @default.
• W45403062 hasAuthorship W45403062A5039432100 @default.
• W45403062 hasAuthorship W45403062A5091717071 @default.
• W45403062 hasConcept C126322002 @default.
• W45403062 hasConcept C141071460 @default.
• W45403062 hasConcept C197934379 @default.
• W45403062 hasConcept C2776761581 @default.
• W45403062 hasConcept C2777077863 @default.
• W45403062 hasConcept C2777575956 @default.
• W45403062 hasConcept C2779134260 @default.
• W45403062 hasConcept C2780484280 @default.
• W45403062 hasConcept C71315377 @default.
• W45403062 hasConcept C71924100 @default.
• W45403062 hasConceptScore W45403062C126322002 @default.
• W45403062 hasConceptScore W45403062C141071460 @default.
• W45403062 hasConceptScore W45403062C197934379 @default.
• W45403062 hasConceptScore W45403062C2776761581 @default.
• W45403062 hasConceptScore W45403062C2777077863 @default.
• W45403062 hasConceptScore W45403062C2777575956 @default.
• W45403062 hasConceptScore W45403062C2779134260 @default.
• W45403062 hasConceptScore W45403062C2780484280 @default.
• W45403062 hasConceptScore W45403062C71315377 @default.
• W45403062 hasConceptScore W45403062C71924100 @default.
• W45403062 hasIssue "6" @default.
• W45403062 hasLocation W454030621 @default.
• W45403062 hasOpenAccess W45403062 @default.
• W45403062 hasPrimaryLocation W454030621 @default.
• W45403062 hasRelatedWork W1963997301 @default.
• W45403062 hasRelatedWork W2020366819 @default.
• W45403062 hasRelatedWork W2063022713 @default.
• W45403062 hasRelatedWork W2082639692 @default.
• W45403062 hasRelatedWork W2313909601 @default.
• W45403062 hasRelatedWork W2369740059 @default.
• W45403062 hasRelatedWork W2408748273 @default.
• W45403062 hasRelatedWork W2414479034 @default.
• W45403062 hasRelatedWork W4247887685 @default.
• W45403062 hasRelatedWork W45403062 @default.
• W45403062 hasVolume "74" @default.
• W45403062 isParatext "false" @default.
• W45403062 isRetracted "false" @default.
• W45403062 magId "45403062" @default.
• W45403062 workType "article" @default.